3greenfield JP,Hoffman C,Boockvar JA.Fallibility of glioblastoma multiforme cell lines overcome by use of tumor-derived stein cell.Neurosurgery,2006,59(2):N9.
4Gadducci A, Cosio S, Zola P, et al. Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature. Int J Gynecol Cancer, 2007,17:21-31.
5Cheung VG, Conlin LK, Weber TM, et al. Natural variation in human gene expression assessed in lymphoblastoid cells. Nat Genet ,2003,33:422-425.
6Tuxen MK, Soletormos G, Petersen PH, et al. Assessment of biological variation and analytical imprecision of CA125, CEA, and TPA in relation to monitoring of ovarian cancer. Gynecol Oncol, 1999,74 : 12-22.
7Berchuck A, O1t GJ, Soisson AP, et al. Heterogeneity of antigen expression in advanced epithelial ovarian cancer. Am J Obstet Gynecol, 1990,162:883-888.
8Tangjitgamol S, See HT, Manusirivithaya S, et al. Third-line chemotherapy in platinum- and paelitaxel-resistant ovarian, fallopian tube, and primary peritoneal carcinoma patients. Int J Gynecol Caneer,2004 ,14 :804-814.
9Rustin GJ, Nelstrop AE, Tuxen MK, et al. Defining progression of ovarian carcinoma during follow-up according to CA125 : a North Thames Ovary Group study. Ann Oncol, 1996, 7:361-364.
10Fioretti P, Gadducci A, Ferdeghini M, et al. The concomitant determination of different serum tumor markers in epithelial ovarian cancer: relevance for monitoring the response to chemotherapy and follow-up of patients. Gynecol Oncol, 1992,44 : 155-160.
4ALAMEDA F,PIJUAN L,LLOVERAS B,et al.The value of p16 in ASCUS cases:a retrospective study using frozen cytologic material[J].Diagn Cytopathol,2011,39(2):110-114.
6GAGE JC,DUGGAN MA,NATION JG,et al.Detection of cervical cancer and its precursors by endocervical curettage in 13,115 colposcopically guided biopsy examinations[J].Am J Obstet Gynecol,2010,203(5):481.
8Berehuck A, Olt GJ, Soisson AP. Heterogeneity of antigen expression in advanced epithelial ovarian cancer [ J ]. Am J Obstet Gynecol, 1990, 162(4) : 883 -888.
9Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cells- perspectives on current status and future directions: AACR Workshop on cancer stem ceils [ J ]. Cancer Res, 2006, 66 (19) : 9339 -9344.
10Greenfield JP, Hoffman C, Boockvar JA. Fallibility of glioblastoma muhiforme cell lines overcome by use of tumor-derived stemcel[ J]. J Neurosurgery,2006, 59 (2) : N9.
